Two weeks ago, Vicore reported mid-stage data showing that its lead drug C21 could boost the benefit of The post Vicore builds case for C21 drug...
Myovant Sciences $MYOV won’t be getting coal in their stocking this Christmas. The Swiss biotech, formerly part of the Vivek Ramaswamy family of Vants, won FDA...
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA The post Moderna and BioNTech – who are...
Eli Lilly & Co. announced plans to launch a pragmatic study of its investigational antibody treatment, bamlanivimab, in high-risk patients with COVID-19. As part of the...
Drugs like ketamine can relieve depression symptoms, including suicidal thoughts, within hours, but they also carry risks that patients need to understand.
Once one of the hottest brands in biotech, Patrick Soon-Shiong’s next-gen cancer brainchild NantKwest has taken its lumps in recent years with little to show from...
Novartis’ cholesterol drug inclisiran has hit a speed bump with the FDA, which has rejected the potential blockbuster The post FDA rejects Novartis’ cholesterol drug after...
Myovant Sciences $MYOV won’t be getting coal in their stocking this Christmas. The UK biotech, part of the Vivek Ramaswamy family of Vants, won FDA approval...
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies...
Credit: NIAID Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research...
Llama toys, therapy lamas, petting zoo llamas: llamas are hot in the US, surpassing unicorns in popularity, but their relationship with South American people stretches over...
Mesoblast, on Friday, reported a failure in achieving the 30-day mortality reduction endpoint during its COVID-19 ARDS (acute respiratory distress syndrome) trial.
74% of office-based businesses are working remotely, with 31% intending to stay that way into the future Q3 2020 hedge fund letters, conferences and more In...
Thermo Fisher Scientific is significantly expanding the company's footprint with new facilities in the United States and in Europe.
Trying to get help for gender dysphoria is rigorous and stressful for young people and their families, it shouldn't be this way.
The real problem may be that a burden of representation means these narratives must ‘do it all’
Cairn Energy announced that it will pay shareholders a special dividend of £188 million ($250 million) following the completion of the sale of its Senegal assets....
Merck & Co. announced on Thursday that the US Food and Drug Administration (FDA) has granted priority review for the use of its lead drug Keytruda in...
A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company The post Ardelyx’s ambition to revolutionise kidney treatment...
Shares of WPP jumped almost 5% after the world’s largest advertising company said that it is making progress on its goal to return to 2019 net...
It’s been a whirlwind week for Thermo Fisher. Over the course of five days prior to Wednesday, the Massachusetts CDMO had announced two major expansion projects...
UK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6 The post EUSA Pharma hopes IL-6 drug will...
Leading biotechnology firm Amgen (AMGN) announced a 10% hike in its quarterly dividend per share to $1.76. Shares were marginally up in the extended trading session...
Lexicon Pharmaceuticals has entered into a collaboration agreement with AC Bioscience, enabling the use of preclinical and clinical data for LX2931, without granting any right or...
A roundup of biopharma news and updates includes Merck and Eisai’s Keytruda-Lenvima combo hitting the mark in a Phase III study for advanced endometrial cancer.
Eli Lilly & Co. has inked an agreement to snap up Prevail Therapeutics for a total consideration of up to $1.04 billion, as the US drugmaker...
Quest Diagnostics Inc. raised its 2020 full-year profit and sales outlook as the diagnostics company said it experienced “significantly” higher COVID-19 molecular testing volumes. Shares rose...
The startup opioid use disorder therapy service Bicycle Health will soon be available to patients in half the country, just three years after its launch in...
AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the The post AbbVie begins trials of COVID-19 antibody...
As the world faces a second wave of COVID-19 lockdowns, we need new strategies to handle pandemic stress that go beyond basic self-care.